Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2010,NCI,5R01CA103937-06,,Molecular Diagnostics for Malignant Effusion,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$338,148"
Ovarian Cancer,2010,NCI,5R01CA131407-03,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$345,843"
Ovarian Cancer,2010,NCI,5R01CA104996-06,,Promoting Tumor Immunity by Cross-linking B7-DC,"PEASE, LARRY",MAYO CLINIC,MN,"$246,712"
Ovarian Cancer,2010,NCI,5R01CA119200-04,,Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$282,610"
Ovarian Cancer,2010,NCI,5R01CA124630-04,,PTTG Role in Ovarian Tumorigenesis and Matastasis,"KAKAR, SHAM",UNIVERSITY OF LOUISVILLE,KY,"$253,080"
Ovarian Cancer,2010,NCI,5R01CA123249-03,,Regulation of Serine Protease HtrA1 and Chemoresponse,"SHRIDHAR, VIJI",MAYO CLINIC,MN,"$313,533"
Ovarian Cancer,2010,NCI,5R01CA114343-04,,Haplotype-Based Genome Screen for Ovarian Cancer Loci,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$1,105,238"
Ovarian Cancer,2010,NCI,5R01CA132091-03,,Targeted Nanoparticle DNA Therapy for Ovarian Cancer,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$275,202"
Ovarian Cancer,2010,NCI,5R21CA132987-02,,Risk of Cancer with Incidental Findings Identified on Ultrasound Imaging,"SMITH-BINDMAN, REBECCA",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$172,697"
Ovarian Cancer,2010,NCI,5R01CA129080-03,,The Roles of HBXAP Gene in Ovarian Cancer,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2010,NICHD,5R01HD057110-03,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$300,757"
Ovarian Cancer,2010,NIGMS,1SC1GM082340-01A2,,The Fulvene Approach to the Syntheses of Antitumor Agents,"ERDEN, IHSAN",SAN FRANCISCO STATE UNIVERSITY,CA,"$268,625"
Ovarian Cancer,2010,NIEHS,5R01ES005775-18,,"Hypoxia, Genetic Instability and DNA Mismatch Repair","GLAZER, PETER",YALE UNIVERSITY,CT,"$368,271"
Ovarian Cancer,2010,NCI,5R01CA120409-05,,Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$266,186"
Ovarian Cancer,2010,NCI,1R01CA142838-01,,Role of redox state in ovarian cancer response to cisplatin,"DANIEL, LARRY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$302,024"
Ovarian Cancer,2010,NCI,1R01CA142832-01,,Novel Biomarkers in Ovarian Cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$377,561"
Ovarian Cancer,2010,NCI,5R01CA079756-10,,P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,"BUCHBERG, ARTHUR",THOMAS JEFFERSON UNIVERSITY,PA,"$238,892"
Ovarian Cancer,2010,NCI,5R01CA060651-18,,Mouse Models to Study Gonadal Tumor Development,"MATZUK, MARTIN",BAYLOR COLLEGE OF MEDICINE,TX,"$266,562"
Ovarian Cancer,2010,NCI,5R01CA123197-04,,Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer,"ZHOU, TONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$459,161"
Ovarian Cancer,2010,NCI,1K07CA143047-01,,Genetic Epidemiology of Ovarian and Prostate Cancer,"SIEH, WEIVA",STANFORD UNIVERSITY,CA,"$173,448"
Ovarian Cancer,2010,NCI,5R01CA133057-02,,Prognostic markers for ovarian cancer,"MOK, SAMUEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Ovarian Cancer,2010,NCI,5R01CA111882-05,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$264,562"
Ovarian Cancer,2010,NCI,1R21CA143616-01,,Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125),"PATANKAR, MANISH",UNIVERSITY OF WISCONSIN MADISON,WI,"$193,793"
Ovarian Cancer,2010,NCI,1R21CA143736-01,,Development of a multimarker urine-based test for early diagnosis and screening o,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$164,756"
Ovarian Cancer,2010,NCI,5R21CA135130-02,,Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ova,"YEO, YOON",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$197,922"
Ovarian Cancer,2010,NCI,5R01CA085289-07,,DNA Methylation and Ovarian Cancer,"NEPHEW, KENNETH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$241,916"
Ovarian Cancer,2010,NCI,1R21CA137681-01A1,,A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers,"CHILES, THOMAS",BOSTON COLLEGE,MA,"$204,233"
Ovarian Cancer,2010,NCI,1R15CA143701-01,,Targeting MRP7 to Overcome Drug Resistance for Ovarian Cancer Therapy by Taxanes,"CHEN, ZHE-SHENG",ST. JOHN'S UNIVERSITY,NY,"$245,250"
Ovarian Cancer,2010,NCI,9R01CA149356-09A2,,The Role of MicroRNAs in Tumor Progression,"PETER, MARCUS",UNIVERSITY OF CHICAGO,IL,"$15,291"
Ovarian Cancer,2010,NCI,2R01CA085566-06A1,,Psychological Intervention for Ovarian Cancer Patients,"MANNE, SHARON",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$577,171"
Ovarian Cancer,2010,NCI,9R01CA144057-06,,Evaluation of Vectors based on group B adenoviruses,"LIEBER, ANDRE",UNIVERSITY OF WASHINGTON,WA,"$323,700"
Ovarian Cancer,2010,NCI,2P01CA087969-11,7547,Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$172,272"
Ovarian Cancer,2010,NCI,2P01CA087969-11,7548,Statistical Methods,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$118,774"
Ovarian Cancer,2010,NCI,2P01CA087969-11,7551,Biologic Specimen Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$488,774"
Ovarian Cancer,2010,NCI,5R01CA095175-07,,Analysis of BRCA1 recombination functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$304,354"
Ovarian Cancer,2010,NCI,5R01CA123219-03,,The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$314,578"
Ovarian Cancer,2010,NCI,5R01CA116674-05,,Epigenetic regulation of cancer/germ-line antigen gene expression,"KARPF, ADAM",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$282,184"
Ovarian Cancer,2010,NCI,5R01CA109298-06,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$358,839"
Ovarian Cancer,2010,NCI,5R01CA051578-18,,A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$236,153"
Ovarian Cancer,2010,NCI,5R01CA136891-02,,A Pooled Analysis to Identify New Ovarian Cancer Risk Factors,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$333,819"
Ovarian Cancer,2010,NCI,5F32CA138153-02,,Multimodality Microendoscope for Metastatic Ovarian Cancer Detection & Treatment,"EVANS, CONOR",MASSACHUSETTS GENERAL HOSPITAL,MA,"$50,474"
Ovarian Cancer,2010,NCI,1R43CA141742-01A1,,"Targeted Radiotherapy of Ovarian Cancer with a Novel, High Payload Radioligand","SANDS, HOWARD","SOLIXIA, INC.",PA,"$161,098"
Ovarian Cancer,2010,NCI,5R01CA101850-06,,ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING,"BAE, YOU",UNIVERSITY OF UTAH,UT,"$271,181"
Ovarian Cancer,2010,NCI,5R01CA116984-05,,G Proteins and Their Receptors in Tumor Cell Metastasis,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$300,580"
Ovarian Cancer,2010,NCI,1R44CA144586-01,,IHC Test for BRCA1 Hereditary Ovarian Cancer,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$163,634"
Ovarian Cancer,2010,NCI,1F32CA144389-01,,"Transcription, Choice and the 3D Architecture of the Inactive X-Chromosome","MUGFORD, JOSHUA",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$47,606"
Ovarian Cancer,2010,NCI,1R43CA144591-01,,EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$149,855"
Ovarian Cancer,2010,NCI,5R01CA124515-04,,Vascular Leukocytes influence the tumor microenvironment,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$303,810"
Ovarian Cancer,2010,NCI,5R01CA138762-02,,Splicing factors as therapeutic targets for the treatment of ovarian cancer,"BECK, WILLIAM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$313,715"
Ovarian Cancer,2010,NCI,7R01CA139159-02,,Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A,"STIERLE, ANDREA",UNIVERSITY OF MONTANA,MT,"$215,936"
Ovarian Cancer,2010,NCI,1F32CA144898-01,,Role of Tumor Microenvironment in Ovarian Cancer Progression,"THOMPSON, MELISSA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$48,206"
Ovarian Cancer,2010,NCI,5R01CA131183-03,,"RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression","LIU, JINSONG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$255,640"
Ovarian Cancer,2010,NCI,5R01CA133117-02,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$336,841"
Ovarian Cancer,2010,NCI,5R01CA136549-02,,Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,"LU, XIONGBIN",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$298,800"
Ovarian Cancer,2010,NCI,5R01CA136491-02,,Development of an Assay for the Early Detection of Ovarian Cancer,"BRARD, LAURENT",WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,"$430,401"
Ovarian Cancer,2010,NCI,5R01CA112523-05,,Steroid Hormone Genes and Ovarian Cancer Risk,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$464,332"
Ovarian Cancer,2010,NCI,5R01CA130911-03,,Chimeric NKG2D receptors in ovarian cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$331,793"
Ovarian Cancer,2010,NCI,5R01CA131200-02,,Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases,"EBLEN, SCOTT",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$305,274"
Ovarian Cancer,2010,NCI,5R01CA122728-03,,Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$344,171"
Ovarian Cancer,2010,NCI,5R01CA114037-04,,Taxane Resistance in Breast and Ovarian Cancer Cells,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$297,730"
Ovarian Cancer,2010,NCI,5R01CA136494-02,,Molecular mechanism of antiangiogenic properties of gold nanoparticle,"MUKHERJEE, PRIYABRATA",MAYO CLINIC,MN,"$282,179"
Ovarian Cancer,2010,NCI,5R01CA131965-02,,Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium,"SWISHER, ELIZABETH",UNIVERSITY OF WASHINGTON,WA,"$323,700"
Ovarian Cancer,2010,NCI,5K08CA106597-05,,Chromatin structure and BRCA1 Checkpoint Function,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$135,677"
Ovarian Cancer,2010,NCI,5R01CA086061-10,,Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticance,"ESSIGMANN, JOHN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$282,619"
Ovarian Cancer,2010,NCI,5R01CA136547-02,,Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer,"GALANIS, EVANTHIA",MAYO CLINIC,MN,"$530,593"
Ovarian Cancer,2010,NCI,5R01CA123088-04,,Novel immunosupressive macrophages in human ovarian tumor,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$288,800"
Ovarian Cancer,2010,NCI,5R01CA135312-03,,Dendritic nanomedicine for cancer imaging and treatment,"TUNG, CHING-HSUAN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$311,250"
Ovarian Cancer,2010,NCI,5R01CA095071-09,,Epithelial Positioning Organization and Ovarian Cancer,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$323,942"
Ovarian Cancer,2010,NCI,5R01CA120429-04,,Regulation of MDR1 Expression and Drug Resistance by CD44,"RODRIGUEZ-RODRIGUEZ, LORNA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$296,400"
Ovarian Cancer,2010,NCI,5R01CA125636-04,,The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$320,565"
Ovarian Cancer,2010,NCI,5R01CA121187-04,,Monitoring of advanced virotherapy for ovarian cancer,"CURIEL, DAVID",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$275,500"
Ovarian Cancer,2010,NCI,5R01CA135179-02,,INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$438,917"
Ovarian Cancer,2010,NCI,5R01CA137041-02,,MicroRNAs in Human Ovarian Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,525"
Ovarian Cancer,2010,NCI,5R01CA127913-03,,MyD88-bearing tumors in immune-regulation and chemo-resistance,"MOR, GIL",YALE UNIVERSITY,CT,"$343,413"
Ovarian Cancer,2010,NCI,5R01CA134424-02,,A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc,"KOSTUK, RAYMOND",UNIVERSITY OF ARIZONA,AZ,"$420,959"
Ovarian Cancer,2010,NCI,5R21CA137686-02,,High-throughput intracellular microrheology: a new tool for cancer research,"WIRTZ, DENIS",JOHNS HOPKINS UNIVERSITY,MD,"$243,480"
Ovarian Cancer,2010,NCI,5R01CA138556-02,,Impact of exercise on ovarian cancer prognosis,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$668,926"
Ovarian Cancer,2010,NCI,5R01CA094172-09,,Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas,"CHO, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$261,178"
Ovarian Cancer,2010,NCI,1R01CA149429-01,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$728,415"
Ovarian Cancer,2010,NCI,5R01CA126841-02,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$629,546"
Ovarian Cancer,2010,NCI,1K08CA148887-01,,Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer,"KHABELE, DINEO",VANDERBILT UNIVERSITY,TN,"$159,084"
Ovarian Cancer,2010,NCI,2U10CA027469-30,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$8,224,605"
Ovarian Cancer,2010,NCI,1R21CA150237-01,,Targeting lipid metabolic and signaling enzyme in ovarian cancer,"NG, SHU-WING",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$217,918"
Ovarian Cancer,2010,NCI,5R03CA142074-02,,Prevention of Menopause-Related Ovarian Epithelial Cancer,"SMITH, ELIZABETH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$76,500"
Ovarian Cancer,2010,NCI,2U54CA113001-06,,Interrogating Epigenetic Changes in Cancer Genomes,"HUANG, TIM",OHIO STATE UNIVERSITY,OH,"$1,596,781"
Ovarian Cancer,2010,NCI,5R43CA135960-02,,Portable photonic sensor system as an early detection tool for ovarian cancer,"WAWRO, DEBRA",RESONANT SENSORS INC.,TX,"$89,216"
Ovarian Cancer,2010,NCI,5R01CA131400-02,,VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER,"SPRINGETT, GREGORY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,525"
Ovarian Cancer,2010,NCI,5R01CA092520-10,,Tumor Host Range Mutants of Polyoma and Their Targets,"BENJAMIN, THOMAS",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$646,176"
Ovarian Cancer,2010,NCI,5K24CA087933-10,,Clinical Investigator Development in Solid Tumor Oncology,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$153,090"
Ovarian Cancer,2010,NIGMS,5R01GM088055-11,,Structural and Functional Characterization of BRCA1/BARD1,"KLEVIT, RACHEL",UNIVERSITY OF WASHINGTON,WA,"$374,448"
Ovarian Cancer,2010,NCI,5R01CA116779-05,,Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$271,456"
Ovarian Cancer,2010,NCI,5R01CA136512-02,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$525,558"
Ovarian Cancer,2010,NCI,2R01CA086984-11,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$301,599"
Ovarian Cancer,2010,NCI,2R01CA099985-04,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$223,679"
Ovarian Cancer,2010,NCI,2R01CA031841-30,,Synthetic Studies on Tumor Promoters and Inhibitors,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$328,087"
Ovarian Cancer,2010,NCI,5R01CA132630-04,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$439,287"
Ovarian Cancer,2010,NCI,1R01CA140323-01A1,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$423,060"
Ovarian Cancer,2010,NCI,1R01CA141078-01A1,,Multifunctional roles of homeobox gene DLX4 in ovarian cancer,"NAORA, HONAMI",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2010,NCI,2R01CA115483-06,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$302,871"
Ovarian Cancer,2010,NCI,2R01CA108970-06,,CD4+ Memory T-Cells in Human Tumor Microenvironment,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$323,034"
Ovarian Cancer,2010,NINR,5R01NR010735-03,,Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed,"DONOVAN, HEIDI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$565,708"
Ovarian Cancer,2010,NCI,5R01CA135006-02,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$441,531"
Ovarian Cancer,2010,NCI,5R01CA140933-02,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$558,863"
Ovarian Cancer,2010,NCI,5R01CA092889-09,,Role of TGFbeta in Microtubule Dynamics,"MULDER, KATHLEEN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$269,269"
Ovarian Cancer,2010,NCI,5R01CA127562-04,,Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer,"UENO, NAOTO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Ovarian Cancer,2010,NCI,5R01CA118678-04,,Apoptotic regulators in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$314,450"
Ovarian Cancer,2010,NICHD,1K99HD059985-01A2,,GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$90,000"
Ovarian Cancer,2010,NCI,1R03CA150039-01,,MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA,"AIKHIONBARE, FELIX",MOREHOUSE SCHOOL OF MEDICINE,GA,"$58,000"
Ovarian Cancer,2010,NCI,5R01CA122581-05,,Tumor-Associated Antigens in Early Stage Serous Carcinoma,"RODEN, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$263,559"
Ovarian Cancer,2010,NCI,5R01CA122443-04,,Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology,"GOODE, ELLEN",MAYO CLINIC,MN,"$492,570"
Ovarian Cancer,2010,NCI,5R44CA123785-03,,Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer,"FLYNN, EDWARD",SENIOR SCIENTIFIC,NM,"$362,274"
Ovarian Cancer,2010,NCI,7R01CA095319-08,,Novel Fas/CD95 Signaling Mechanisms,"PETER, MARCUS",NORTHWESTERN UNIVERSITY,IL,"$273,024"
Ovarian Cancer,2010,NCI,5K25CA120350-04,,A near-infrared contrast agent for targeted imaging of cancer,"ROMANOWSKI, MAREK",UNIVERSITY OF ARIZONA,AZ,"$141,776"
Ovarian Cancer,2010,NCI,5K25CA128666-04,,Comparative Proteomics Applied to the Avian Model of Ovarian Cancer,"HAWKRIDGE, ADAM",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$143,370"
Ovarian Cancer,2010,NCI,5R01CA075334-13,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,771"
Ovarian Cancer,2010,NCI,5R01CA118158-05,,The role of BRCA1 in nonhomologous repair of chromosomal double-strand breaks,"XIA, FEN",VANDERBILT UNIVERSITY,TN,"$238,105"
Ovarian Cancer,2010,NCI,5R21CA132026-02,,Boosting anti-tumor immune responses by modulating genes with nanoparticles,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$205,073"
Ovarian Cancer,2010,NCI,5R01CA118578-06,,The Mechanism of BRCA1 in Tumor Suppression,"HU, YANFEN",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$201,308"
Ovarian Cancer,2010,NCI,5R01CA120061-06,,Hormone levels during pregnancy and maternal ovarian cancer,"LUKANOVA, ANNEKATRIN",GERMAN CANCER RESEARCH CENTER,GERM,"$379,595"
Ovarian Cancer,2010,NHGRI,5R01HG005055-03,,INTERNET INTERVENTION FOR BRCA1/BRCA2 UNINFORMATIVES,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$555,028"
Ovarian Cancer,2010,NCI,5R33CA122904-04,,Identification of T Cell-Defined Antigens in Ovarian Cancer,"YEE, CASSIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$391,253"
Ovarian Cancer,2010,NCI,5R01CA058598-12,,Collaborative Genetic Study of Ovarian Cancer Risk,"GOODMAN, MARC",UNIVERSITY OF HAWAII AT MANOA,HI,"$534,918"
Ovarian Cancer,2010,NHLBI,1R43HL099217-01A1,,ChNKG2D-Targeted Cellular Cancer Therapy: Preclinical Toxicology,"SENTMAN, CARIN","CELDARA MEDICAL, LLC",NH,"$413,428"
Ovarian Cancer,2010,NCI,1R43CA154339-01,,Magnetic Nanoparticles and Quantum Dots for Diagnosis of Early Stage Ovarian Canc,"AGUILAR, ZORAIDA","OCEAN NANOTECH, LLC",AR,"$150,075"
Ovarian Cancer,2010,NICHD,5K12HD055881-04,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$50,000"
Ovarian Cancer,2010,OD,5K12HD055881-04,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$446,801"
Ovarian Cancer,2010,NCI,5R01CA129142-02,,Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women,"KINNEY, ANITA",UNIVERSITY OF UTAH,UT,"$609,137"
Ovarian Cancer,2010,NCI,1R13CA139632-01A1,,Joining FORCEs Against Hereditary Cancer:  Annual Conference on Hereditary Breast,"LARONGA, CHRISTINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$8,000"
Ovarian Cancer,2010,NCI,5R01CA136596-02,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",FOX CHASE CANCER CENTER,PA,"$325,879"
Ovarian Cancer,2010,NCI,5K07CA131094-03,,Epigentics and Female Reproductive Cancers,"PERRIN, MARY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$139,320"
Ovarian Cancer,2010,NCI,1R03CA139905-01A2,,Sociocultural Factors and BRCA Genetic Counseling for Diverse Latinas,"SUSSNER, KATARINA",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$83,986"
Ovarian Cancer,2010,NCI,1R01CA142081-01A1,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",DUKE UNIVERSITY,NC,"$2,191,541"
Ovarian Cancer,2010,NCI,5K07CA108987-05,,Clinical Relevance of Mismatch Repair in Ovarian Cancer,"PAL, TUYA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$132,823"
Ovarian Cancer,2010,NCI,5R01CA134487-03,,Mesothelin as biomarker and therapeutic target,"HELLSTROM, INGEGERD",UNIVERSITY OF WASHINGTON,WA,"$270,000"
Ovarian Cancer,2010,NCI,5K25CA111636-07,,Clinico-Genomics for Improved Ovarian Cancer Treatment,"CLARKE, JENNIFER",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$60,119"
Ovarian Cancer,2010,NCI,5K99CA134750-02,,The Role of the Microenvironment in Early Ovarian Cancer Metastasis,"KENNY, HILARY",UNIVERSITY OF CHICAGO,IL,"$111,389"
Ovarian Cancer,2010,NCI,5R33CA110499-04,,Molecular Profiling to Predict Response to Chemotherapy,"LANCASTER, JOHNATHAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$276,313"
Ovarian Cancer,2010,NCI,5R42CA124191-03,,BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$307,776"
Ovarian Cancer,2010,NCI,5R01CA127239-03,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$278,966"
Ovarian Cancer,2010,NCI,5R21CA141241-02,,Development and Pilot Test of an Elective BSO Decision Support Guide,"KUPPERMANN, MIRIAM",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$169,950"
Ovarian Cancer,2010,NCI,1U19CA148112-01,8865,Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$618,841"
Ovarian Cancer,2010,NCI,1U19CA148112-01,8866,"Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)","SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$986,904"
Ovarian Cancer,2010,NCI,1U19CA148112-01,8867,Functional assessment of genes and common genetic risk variants in ovarian cancer,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$583,252"
Ovarian Cancer,2010,NCI,1U19CA148112-01,8868,Genetic and environmental interaction analyses and risk prediction modeling,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$592,661"
Ovarian Cancer,2010,NCI,5R01CA083855-11,,Prophytactic surgery in carriers of BRCA 1/2 mutations,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$709,500"
Ovarian Cancer,2010,NCI,5R01CA118846-04,,Regulation of gene silencing by exogenous sphingosine,"SCHMELZ, EVA",VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,"$271,035"
Ovarian Cancer,2010,NIAID,5SC1AI089073-02,,Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$362,588"
Ovarian Cancer,2010,NCI,5R03CA139492-02,,"Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer","BURDETTE, JOANNA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$78,500"
Ovarian Cancer,2010,NCI,5SC2CA150317-02,,Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors,"AIKHIONBARE, FELIX",MOREHOUSE SCHOOL OF MEDICINE,GA,"$140,000"
Ovarian Cancer,2010,NCI,1R01CA151374-01,,Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients,"MARTIN, LAINIE",FOX CHASE CANCER CENTER,PA,"$407,574"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$917,914"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$199,352"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS,,"$200,426"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$180,145"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$179,800"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7771,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$25,172"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$276,498"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7773,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$117,295"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7774,Developmental Research Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$80,910"
Ovarian Cancer,2010,NCI,2P50CA083639-11,7775,Career Developmental Program,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$53,940"
Ovarian Cancer,2010,NCI,1U01CA151461-01,,Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer,"O'HALLORAN, THOMAS",NORTHWESTERN UNIVERSITY,IL,"$461,174"
Ovarian Cancer,2010,NCI,1U01CA151648-01,,RNA Nanotechnology in Cancer Therapy,"GUO, PEIXUAN",UNIVERSITY OF CINCINNATI,OH,"$485,825"
Ovarian Cancer,2010,NCI,5F32CA142117-02,,Modulation of tumor-associated macrophage phenotype by S1P receptors,"BLAHO, VICTORIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$52,154"
Ovarian Cancer,2010,NICHD,1R15HD066302-01,,Receptor/Ligand Signals for Ovarian Follicular Angiogenesis,"SPICER, LEON",OKLAHOMA STATE UNIVERSITY STILLWATER,OK,"$352,346"
Ovarian Cancer,2010,RMAP,1DP2OD007096-01,,Imaging and Overcoming Hypoxia-Induced Resistance in Metastatic Ovarian Cancer,"EVANS, CONOR",MASSACHUSETTS GENERAL HOSPITAL,MA,"$2,655,000"
Ovarian Cancer,2010,RMAP,1DP2OD007391-01,,ULTRASENSITIVE NANOLASERS FOR EPIGENETICS INVESTIGATIONS,"ARMANI, ANDREA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$2,430,000"
Ovarian Cancer,2010,NCI,1U01CA152637-01,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$859,566"
Ovarian Cancer,2010,NCI,1U54CA151662-01,8772,Magnetic nanoparticle Immunotherapy against Ovarian Cancer,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$244,217"
Ovarian Cancer,2010,NCI,1U54CA151662-01,8775,"Toxicology, Pathology and Biodistribution Core (TPB Core)","LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$95,876"
Ovarian Cancer,2010,NCI,2U01CA084955-11,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$513,677"
Ovarian Cancer,2010,NCI,1U01CA152755-01,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$301,643"
Ovarian Cancer,2010,NCI,1U54CA151668-01,8844,Multistage Vectors (MSV) for Ovarian Cancer Therapeutics,"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$744,984"
Ovarian Cancer,2010,NCI,1U54CA151668-01,8845,Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$339,218"
Ovarian Cancer,2010,NCI,1U54CA151668-01,8847,Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri,"ARAP, WADIH",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$306,459"
Ovarian Cancer,2010,NCI,1U54CA151459-01,8855,Next Generation Smart Nanoparticles,"ALIVISATOS, PAUL",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$1,099,581"
Ovarian Cancer,2010,NCI,1U54CA151459-01,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$292,060"
Ovarian Cancer,2010,NCI,1U54CA151459-01,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$193,500"
Ovarian Cancer,2010,NCI,1U54CA151459-01,8865,Pilot Projects,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$60,200"
Ovarian Cancer,2010,NCI,5F31CA144083-02,,Defining double-stranded RNA receptor induced apoptosis in ovarian cancer.,"SCHRAMM, DANIELLE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$32,470"
Ovarian Cancer,2010,NCI,1U54CA151819-01,8878,"Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an","HOOD, LEROY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$761,694"
Ovarian Cancer,2010,NCI,1U54CA151819-01,8879,Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$381,654"
Ovarian Cancer,2010,NCI,1U54CA151819-01,8883,Administrative Core,"HEATH, JAMES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$116,136"
Ovarian Cancer,2010,NCI,1U54CA151884-01,5023,Nanoformulations for siRNA Delivery to Ovarian Cancer,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$269,012"
Ovarian Cancer,2010,NCI,1U54CA151881-01,5122,Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$853,888"
Ovarian Cancer,2010,NCI,1U54CA151881-01,5124,Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance,"MINKO, TAMARA",RUTGERS THE STATE UNIVERSITY OF NJ,NJ,"$290,904"
Ovarian Cancer,2010,NCI,2R01CA115780-05A1,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$285,016"
Ovarian Cancer,2010,NCI,1R01CA138628-01A2,,Role of the BMP SMADs in Oncogenesis,"PANGAS, STEPHANIE",BAYLOR COLLEGE OF MEDICINE,TX,"$162,369"
Ovarian Cancer,2010,NCI,1R01CA149260-01A1,,Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy,"KUO, MACUS",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$327,850"
Ovarian Cancer,2010,NCI,7R01CA123233-03,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$248,751"
Ovarian Cancer,2010,NCI,1R01CA138533-01A1,,Multifunctional Nanotherapeutics for Cancer Treatment and Imaging,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$329,466"
Ovarian Cancer,2010,NIBIB,1R01EB011523-01A1,,Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu,"CHOI, HAK SOO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$513,850"
Ovarian Cancer,2010,NCI,2R01CA108990-06,,Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$322,540"
Ovarian Cancer,2010,NCI,1R01CA142783-01A1,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$313,652"
Ovarian Cancer,2010,NCI,1R01CA141154-01A2,,Identifying Ovarian Cancer Susceptibility Alleles using Genome-Wide Scan Data,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$716,356"
Ovarian Cancer,2010,NCI,1K22CA138563-01A2,,Obesity in ovarian cancer prognosis,"BANDERA, ELISA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$203,040"
Ovarian Cancer,2010,NCI,1U01CA152990-01,,"Proteomic, Genetic & Longitudinal Pathways to Ovarian Cancer Biomarker Discovery","SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$711,452"
Ovarian Cancer,2010,OD,1R03CA141318-01A1,,Nuclear Pore Complex Architecture and Drug Resistance in Ovarian Carcinomas,"KOHTZ, DONALD",MOUNT SINAI SCHOOL OF MEDICINE,NY,"$84,750"
Ovarian Cancer,2010,NICHD,1R03HD058909-01A2,,Regulation of Fetal Ovarian Development by GATA4,"BOUMA, GERRIT",COLORADO STATE UNIVERSITY-FORT COLLINS,CO,"$73,500"
Ovarian Cancer,2010,NCI,1R01CA148747-01A1,,Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer,"CLIBY, WILLIAM",MAYO CLINIC,MN,"$163,614"
Ovarian Cancer,2010,NCI,2R01CA099471-06A2,,Gonadotropins & Cox-2 in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$400,502"
Ovarian Cancer,2010,NINR,1F31NR012341-01,,"Prophylactic, risk-reducing surgery in BRCA-positive women:  sexual functioning a","TOLLIN, SHARON",UNIVERSITY OF SOUTH FLORIDA,FL,"$30,146"
Ovarian Cancer,2010,NCI,1R41CA144818-01A1,,Targeted Polymeric Combination Delivery for Treatment of Ovarian Cancer,"GHANDEHARI, HAMID",THERATARGET,UT,"$100,000"
Ovarian Cancer,2010,NCI,1F32CA154044-01,,Ruth L. Kirschstein National Research Service Awards for Individual Postdoctoral,"CHEUNG, ANN",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$47,606"
Ovarian Cancer,2010,NCI,1F31CA145736-01A1,,Smart Packaging: A Novel Technique for Localized Drug Delivery for Ovarian Cancer,"WILLIAMS, EVA CHRISTABEL",UNIVERSITY OF SOUTH FLORIDA,FL,"$30,925"
Ovarian Cancer,2010,RMAP,1R01CA156695-01,,Transformative personalized vascular disrupting cancer immunotherapy,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$635,042"
Ovarian Cancer,2010,NCI,5P01CA070970-12,0006,Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$354,656"
Ovarian Cancer,2010,NCI,5P30CA006516-46,9035,Core - Rapid Case Identification,"MUELLER, NANCY",DANA-FARBER CANCER INSTITUTE,MA,"$215,473"
Ovarian Cancer,2010,NCI,3R01CA060651-18S1,,Mouse Models to Study Gonadal Tumor Development,"MATZUK, MARTIN",BAYLOR COLLEGE OF MEDICINE,TX,"$14,690"
Ovarian Cancer,2010,NCI,5P30CA014089-35,9001,Molecular and Cell Biology,"LANDOLPH, JOSEPH",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$439,553"
Ovarian Cancer,2010,NCI,5P30CA014089-35,9005,Transgenic/Knockout Mouse Core Facility,"MAXSON, ROBERT",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$255,808"
Ovarian Cancer,2010,NCI,3R21CA137686-02S1,,High-throughput intracellular microrheology: a new tool for cancer research,"WIRTZ, DENIS",JOHNS HOPKINS UNIVERSITY,MD,"$73,239"
Ovarian Cancer,2010,NCI,N1CN25476A-83-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$3,277,040"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7964,Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$143,955"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7965,Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$279,066"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7966,MicroRNA Signature of Poorly Resectable Ovarian Cancer,"TEWARI, MUNEESH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$219,457"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7967,Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$273,694"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7968,Vaccinating against IGFBP-2 to prevent ovarian cancer relapse,"DISIS, MARY",UNIVERSITY OF WASHINGTON,WA,"$369,911"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7969,Leadership and Administration Core,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$153,682"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7970,Clinical Specimen Management and Characterization Core,"KNUDSEN, BEATRICE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$297,940"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7971,"Participant Recruitment, Enrollment and Characterization Core","DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$264,325"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7972,Biostatistics and Informatics Core,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$161,642"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7973,Developmental Research Program,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$68,164"
Ovarian Cancer,2010,NCI,5P50CA083636-12,7974,Career and Mentoring Development Program,"COLLINS, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$68,164"
Ovarian Cancer,2010,NCI,N02CN63300-5-0-4,,Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$381,429"
Ovarian Cancer,2010,NCI,4R44CA140047-02,,Cancer Progeniyor Cell Markers,"CHEN, WEN-TIEN","VITATEX, INC.",NY,"$702,879"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7923,Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$351,800"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7924,Mechanisms of Immune Suppression in Ovarian Cancer,"KNUTSON, KEITH",MAYO CLINIC,MN,"$279,645"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7925,Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer,"GALANIS, EVANTHIA",MAYO CLINIC,MN,"$396,237"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7926,Flavopiridol Reverses Platinum Resistance in Ovarian Cancer,"BIBLE, KEITH",MAYO CLINIC,MN,"$248,246"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7927,Administration Core,"HARTMANN, LYNN",MAYO CLINIC,MN,"$206,482"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7928,Biospecimens/Patient Registry Core,"BELL, DEBRA",MAYO CLINIC,MN,"$204,180"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7929,Biostatistics Core,"OBERG, ANN",MAYO CLINIC,MN,"$218,559"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7930,Animal Models,"KNUTSON, KEITH",MAYO CLINIC,MN,"$188,653"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7931,Developmental Research Program,"KAUFMANN, SCOTT",MAYO CLINIC,MN,"$137,465"
Ovarian Cancer,2010,NCI,5P50CA136393-02,7932,Career Development Program,"COUCH, FERGUS",MAYO CLINIC,MN,"$68,733"
Ovarian Cancer,2010,NCI,5P01CA129186-04,0002,"HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY","GLAZER, PETER",YALE UNIVERSITY,CT,"$321,820"
Ovarian Cancer,2010,NCI,3P50CA105009-05S2,,Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$500,000"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7949,Gene Methylation Signatures for Predictive Classification of Response to Therapy,"CAIRNS, PAUL",FOX CHASE CANCER CENTER,PA,"$304,215"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7950,Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C,"DALY, MARY",FOX CHASE CANCER CENTER,PA,"$441,569"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7951,Therapeutic Micro RNA Strategies for Ovarian Cancer,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$522,716"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7952,Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$341,238"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7955,Advancing T cell Therapy for Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$542,075"
Ovarian Cancer,2010,NCI,5P50CA083638-12,7956,Administrative Core,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$148,187"
Ovarian Cancer,2010,NCI,4R00CA133190-03,,Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer,"COWDEN DAHL, KAREN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$249,000"
Ovarian Cancer,2010,NCI,5U54CA096297-08,0008,"Synthesis and Pre-Clinical Evaluation of Targeted, Iron-Based MRI Contrast Agents","RAPTIS, RAPHAEL",UNIVERSITY OF PUERTO RICO,PR,"$172,803"
Ovarian Cancer,2010,NIAID,5P01AI068730-04,0005,COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$121,442"
Ovarian Cancer,2010,NCI,5F31CA134188-02,,Boosting therapeutic immunity against Ovarian Cancer through CD40/TLR agonists,"SCARLETT, UCIANE",DARTMOUTH COLLEGE,NH,"$41,380"
Ovarian Cancer,2010,NCI,3R01CA127239-03S1,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$90,477"
Ovarian Cancer,2010,NCI,3R01CA115780-05A1S1,,Diagnosis of Ovarian Cancer by Confocal Microendoscopy,"GMITRO, ARTHUR",UNIVERSITY OF ARIZONA,AZ,"$44,494"
Ovarian Cancer,2010,NCI,3R01CA115483-06S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$8,892"
Ovarian Cancer,2010,NCI,3R01CA115483-06S2,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$47,903"
Ovarian Cancer,2010,NCI,3R01CA086984-11S1,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$33,329"
Ovarian Cancer,2010,NCI,3R01CA115483-06S3,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$10,070"
Ovarian Cancer,2010,NCI,N1CN25522A-98-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$906,613"
Ovarian Cancer,2010,NCI,N1CN25515A-91-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH/ EDUCATION INST,HI,"$1,250,136"
Ovarian Cancer,2010,NCI,N1CN75022A-66-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$516,583"
Ovarian Cancer,2010,NCI,N1CN25524A-81-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$1,146,945"
Ovarian Cancer,2010,NCI,N1CN25518A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$691,713"
Ovarian Cancer,2010,NCI,N1CN25514A-86-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$938,510"
Ovarian Cancer,2010,NCI,N1CN25513A-96-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,651,264"
Ovarian Cancer,2010,NCI,N1CN25511A-91-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","WEISSFELD, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$949,175"
Ovarian Cancer,2010,NIA,1ZIAAG000395-03,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"MORIN, PATRICE",NIH,,"$412,556"
Ovarian Cancer,2010,NIA,1ZIAAG000396-03,,Mechanisms of drug resistance in ovarian cancer,"MORIN, PATRICE",NIH,,"$255,392"
Ovarian Cancer,2010,NIA,1ZIAAG000397-03,,Claudin-7 in ovarian cancer,"MORIN, PATRICE",NIH,,"$196,455"
Ovarian Cancer,2010,NIA,1ZIAAG000398-03,,Expression and roles of microRNAs in ovarian tumorigenesis,"MORIN, PATRICE",NIH,,"$196,455"
Ovarian Cancer,2010,NIDDK,1ZIADK047039-04,,Mechanism of action of STAMP - a new comodulator of glucocorticoid receptors,"SIMONS, S STONEY",NIH,,"$252,689"
Ovarian Cancer,2010,NHGRI,1ZIAHG000120-14,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$126,813"
Ovarian Cancer,2010,NCI,N1CN25512A-111-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$1,192,204"
Ovarian Cancer,2010,NCI,1ZIABC009052-21,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$1,702,735"
Ovarian Cancer,2010,NCI,1ZIABC010579-07,,Papillomavirus Virion Proteins and Vaccines,"LOWY, DOUGLAS",NIH,,"$1,133,390"
Ovarian Cancer,2010,NCI,1ZIABC010891-03,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$464,972"
Ovarian Cancer,2010,NCI,1ZIABC010935-03,,Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,"STRACKE, MARY",NIH,,"$331,594"
Ovarian Cancer,2010,NCI,1ZIABC011054-03,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$447,991"
Ovarian Cancer,2010,NCI,1ZIABC011188-02,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$789,453"
Ovarian Cancer,2010,NCI,1ZIABC011197-02,,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"APPELLA, ETTORE",NIH,,"$355,956"
Ovarian Cancer,2010,NCI,1ZIABC011308-01,,Expression Profiles in ATL Patients,"MASISON, CYNTHIA",NIH,,"$185,379"
Ovarian Cancer,2010,NCI,1ZIABC011311-01,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$307,705"
Ovarian Cancer,2010,NCI,1ZIABC011315-01,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$63,998"
Ovarian Cancer,2010,NCI,1ZIABC011353-01,,Development and validation of preclinical mouse model for serous ovarian cancer,"VAN DYKE, TERRY",NIH,,"$1,107,608"
Ovarian Cancer,2010,NCI,1ZIACP010145-11,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$1,490,914"
Ovarian Cancer,2010,NCI,1ZIACP010152-11,,PLCO Trial Etiologic and Early Marker Study,"HSING, ANN",NIH,,"$1,353,729"
Ovarian Cancer,2010,NCI,1ZIASC009163-23,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$217,297"
Ovarian Cancer,2010,NCI,1ZIASC009374-19,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$252,065"
Ovarian Cancer,2010,NCI,1ZIASC009375-18,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$304,217"
Ovarian Cancer,2010,NCI,1ZICBC010930-03,,Molecular Cytogenetics Core,"ROSCHKE, ANNA",NIH,,"$423,334"
Ovarian Cancer,2010,NCI,1ZICBC010953-03,,Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"SIMPSON, ROBERT",NIH,,"$1,260,079"
Ovarian Cancer,2010,NCI,1ZIHBC010470-08,,Bioinformatic Tools in Cancer Research,"BUETOW, KENNETH",NIH,,"$683,082"
Ovarian Cancer,2010,NCI,261201000069C-0-0-1,,TAS::75 0849::TAS MAGNETICALLY ENERGIZED NANOPARTICLES FOR TREATING OVARIAN CANC,"BARRY, STEPHEN","ASPEN MEDISYS, LLC",MA,"$200,000"
Ovarian Cancer,2010,NCRR,2G12RR003032-26,6360,DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$126,573"
Ovarian Cancer,2010,NCRR,3G12RR003037-25S4,6384,ROLES OF MSP58 IN NUCLEAR FUNCTION AND ONCOGENESIS,"ZHONG, HUALIN",HUNTER COLLEGE,NY,"$83,949"
Ovarian Cancer,2010,NCRR,5P20RR016477-10,7515,A MECHANISM FOR C-SRC ACTIVATION IN OVARIAN CANCER,"SHURINA, ROBERT",MARSHALL UNIVERSITY,WV,"$193,152"
Ovarian Cancer,2010,NCRR,5P20RR016477-10,7517,"PI3K, AKT AND ERR-ALPHA PATHWAYS IN FLAVONOID-INHIBITING TUMORIGENESIS","CHEN, ALLAN",MARSHALL UNIVERSITY,WV,"$200,546"
Ovarian Cancer,2010,NCRR,5P20RR016479-10,7825,ANTI-OVARIAN CANCER PROPERTIES OF RU-486,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$2,531"
Ovarian Cancer,2010,NCRR,5P20RR016479-10,7859,ROLE OF MUC16 IN METASTASIS AND IMMUNE EVASION IN EPITHELIAL OVARIAN CANCER,"GUBBELS, JENNIFER",UNIVERSITY OF SOUTH DAKOTA,SD,"$48,856"
Ovarian Cancer,2010,NCRR,5P20RR016481-10,8121,MECHANISMS IN REGULATING DNA DAMAGE-INDUCED GENES IN A UMUC-DEFICIENT BACTERIUM,"HARE, JANELLE",UNIVERSITY OF LOUISVILLE,KY,"$126,717"
Ovarian Cancer,2010,NCRR,2P41RR002250-25,8394,NANOPARTICLE UPTAKE BY OVARIAN CANCER CELLS,"TARI, ANA",BAYLOR COLLEGE OF MEDICINE,TX,"$10,750"
Ovarian Cancer,2010,NCRR,2P41RR002250-25,8416,OVARIAN CANCER PLATELETS,"SOOD, ANIL",BAYLOR COLLEGE OF MEDICINE,TX,"$4,300"
Ovarian Cancer,2010,NCRR,2P41RR000954-33,8644,HOST AND TUMOR CELL IPLA2 IN OVARIAN CANC,"LI, HUI",WASHINGTON UNIVERSITY,MO,"$11,452"
Ovarian Cancer,2010,NCRR,5P41RR015301-08,5243,STRUCTURE OF THE PROMETASTATIC ENZYME AUTOTAXIN,"BRADDOCK, DEMETRIOS",CORNELL UNIVERSITY ITHACA,NY,"$6,970"
Ovarian Cancer,2010,NCRR,5P41RR008079-18,6387,MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY OF THE OVARIES AT 3 TESLA,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$25,670"
Ovarian Cancer,2010,NCRR,5P51RR000163-51,5250,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$74,561"
Ovarian Cancer,2010,NIA,5P51RR000163-51,5250,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,519"
Ovarian Cancer,2010,NCRR,5P51RR000163-51,5272,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$46,653"
Ovarian Cancer,2010,NIA,5P51RR000163-51,5272,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$950
Ovarian Cancer,2010,NCRR,5P51RR000163-51,5322,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$55,955"
Ovarian Cancer,2010,NIA,5P51RR000163-51,5322,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,140"
Ovarian Cancer,2010,NCI,1ZIABC010549-08,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$979,987"
Ovarian Cancer,2010,NCI,261200800001E-26-0-67,,TCGA Molecular Analysis and Cancer Transcriptome Characterization,"ARTHUR, LARRY","SAIC-FREDERICK, INC.",MD,"$2,479,250"
Ovarian Cancer,2010,NCI,2P30CA014236-36,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$29,330"
